Download full report with analyst certification and important disclosures
Feb 24 2023, 07:15 GMT
CVS Group
H1 results show above forecast margins
- Sectors : Pharma and healthcare
- Companies : CVS Group
DAVY VIEW
CVS’ interim results had largely been announced with the trading statement in January and reflect the execution of its strategy in line with targets announced at the Capital Markets Day. Organic top-line growth is strong, and the EBITDA margin of 19.5% is above forecast with higher interest charges and taxes.
